The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 19, 2021

Filed:

Nov. 09, 2018
Applicant:

Hoffmann—la Roche Inc., Little Falls, NJ (US);

Inventors:

Maria Amann, Schlieren, CH;

Peter Bruenker, Schlieren, CH;

Christina Claus, Schlieren, CH;

Claudia Ferrara Koller, Schlieren, CH;

Sandra Grau-Richards, Schlieren, CH;

Christian Klein, Schlieren, CH;

Viktor Levitski, Schlieren, CH;

Ekkehard Moessner, Schlieren, CH;

Pablo Umana, Schlieren, CH;

Assignee:

Hoffmann-La Roche Inc., Little Falls, NJ (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/18 (2006.01); A61K 47/65 (2017.01); A61P 35/00 (2006.01); C07K 14/525 (2006.01); A61K 47/68 (2017.01); C07K 14/715 (2006.01); C07K 16/24 (2006.01);
U.S. Cl.
CPC ...
C07K 16/18 (2013.01); A61K 47/65 (2017.08); A61K 47/6813 (2017.08); A61K 47/6845 (2017.08); A61P 35/00 (2018.01); C07K 14/525 (2013.01); C07K 14/7151 (2013.01); C07K 16/241 (2013.01); C07K 2319/30 (2013.01);
Abstract

The invention relates to novel TNF family ligand trimer-containing antigen binding molecules comprising (a) at least one antigen binding moiety capable of specific binding to Tenascin-C (TnC) and (b) a first and a second polypeptide that are linked to each other by a disulfide bond, wherein the antigen binding molecules are characterized in that the first polypeptide comprises two ectodomains of a TNF ligand family member or two fragments thereof that are connected to each other by a peptide linker and in that the second polypeptide comprises only one ectodomain of said TNF ligand family member or a fragment thereof. The invention further relates to methods of producing these molecules and to methods of using the same.


Find Patent Forward Citations

Loading…